Drug Database
Back to search

Poland· PL-100081573

Polfilin

A pentoxifylline product containing pentoxifyllinum, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A.. The same ATC class is registered in 12 of our 19 countries.

ATC C04AD03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedPolfilinATCC04AD03REGISTER NO.PL-100081573PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pentoxifyllinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pentoxifylline is registered in 12 of 19 countries.

Countries holding a registration under ATC C04AD03 (pentoxifylline), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search pentoxifylline products by name

Pentoxifylline · ATC C04AD03

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Pentoxifyllinum
Manufacturer
Zakłady Farmaceutyczne POLPHARMA S.A.
Country
Poland (PL)
ATC code
C04AD03
ATC class
Pentoxifylline
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990772414

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

435 interactions on record for pentoxifylline.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pentoxifylline against other medicinesHow interaction checks work

Pentoxifylline · interactions on record

435 records

  • 4 severe
  • 252 moderate
  • 179 info

Most severe, free to view

  • CimetidineA02BA01moderate
  • PapaverineA03AD01moderate
  • Obeticholic acidA05AA04moderate
  • MannitolA06AD16moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pentoxifylline in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pentoxifylline products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Pentomer Retard, Pentoxi Retard
  • Belgium · Torental
  • Bulgaria · Агапурин, Агапурин Sr
  • Cyprus · Angiopent Retard, Tarοntal
  • Czechia · Agapurin, Pentomer Retard
  • Germany · Pentoxifyllin 1 A Pharma, Pentoxifyllin Ratiopharm
  • Estonia · Pentilin, Vasonit Retard
  • Spain · Elorgan, Hemovás
  • France · Pentoxifylline Lp Biogaran, Pentoxifylline Lp Eg
  • United Kingdom (Northern Ireland) · Pentoxifylline Neuraxpharm Uk
  • Greece · Tarontal
  • Croatia · Pentilin, Trental
  • Hungary · Chinotal, Pentoxyl
  • Italy · Trental
  • Lithuania · Agapurin, Pentilin
  • Luxembourg · Pentoxifylline Ratiopharm, Torental
  • Latvia · Pentilin, Polfilin
  • Netherlands · Trental
  • Norway · Trental
  • Portugal · Pentoxifilina Generis, Trental
  • Romania · Angiopent Retard, Pentoxi Retard
  • Slovenia · Pentilin
  • Slovakia · Agapurin, Agapurin Sr

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/af1cd03f-e298-4170-9538-acd7ba7164af
GET /v1/drugs/af1cd03f-e298-4170-9538-acd7ba7164af?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań",
  "source": "urpl",
  "strength": "100 mg",
  "packaging": "05909990772414 ¦ Rp ¦ 12275\n5 amp. 5 ml",
  "substance": "Pentoxifyllinum 100 mg",
  "common_name": "Pentoxifyllinum",
  "pl_product_id": "100081573",
  "pozwolenie_nr": "07724",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about pentoxifylline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console